PF-7006, an Mps1 kinase inhibitor, exhibits a Ki value of 0.27 nM and an IC50 value of 2.5 nM. It disrupts cell cycle checkpoints by inhibiting the catalytic activity of Mps1, reduces histone H3 levels, and shortens the duration of mitosis, thereby inducing apoptosis (Apoptosis) in cancer cells. When used in combination with Palbociclib, the tolerance of cancer cells to PF-7006 is enhanced. PF-7006 is applicable for research on breast cancer.
Molecular Weight:
434.49
CAS Number:
[2771955-09-8]
Formula:
C22H26N8O2
Target:
Apoptosis|||Kinesin
T200142
* VAT and and shipping costs not included. Errors and price changes excepted
